Contact us at 914-666-4665

Dr. Daniel Cameron

Board-certified physician with 38+ years specializing in Lyme disease and tick-borne illnesses. Past President of ILADS (International Lyme and Associated Diseases Society) and first author of ILADS treatment guidelines. Dr. Cameron operates a solo practice focused on patient advocacy and evidence-based Lyme disease treatment. He is the author of 1,100+ articles spanning diagnosis, treatment, co-infections, and recovery from tick-borne illnesses. His work challenges conventional approaches that often leave patients undiagnosed or undertreated, emphasizing clinical judgment over rigid adherence to testing criteria that frequently produce false negatives.

Dr. Daniel Cameron

Lyme disease myths lead to frustrations for doctors

Doctors have also shared their frustration in a survey taken by Dr. Lynora Saxinger, an infectious disease specialist and associate professor at the University of Alberta’s medical school. Lyme disease myths may lead to frustrations for doctors. The survey reported that “30% [of doctors] said they have been pressured to give antibiotics and almost 90% […]

Lyme disease myths lead to frustrations for doctors Read More »

Can Controlled Burns Reduce Tick Populations?

Can Controlled Burns Reduce Tick Populations? Researchers continue to explore ways to reduce tick populations and lower the risk of tick-borne diseases such as Lyme disease. One strategy that has received attention is the use of controlled burns in forested areas. In a study examining tick populations in eastern Texas, Hodo and colleagues evaluated whether

Can Controlled Burns Reduce Tick Populations? Read More »

Can Lyme Disease Be Fatal? When Untreated Lyme Carditis Leads to Death

Can Lyme Disease Be Fatal? When Untreated Lyme Carditis Leads to Death Quick Answer: Lyme disease is rarely fatal, but untreated Lyme carditis can lead to dangerous heart rhythm abnormalities and sudden death. When cardiac symptoms appear, antibiotics should not be delayed. Can you die from Lyme disease? While uncommon, untreated Lyme carditis can cause

Can Lyme Disease Be Fatal? When Untreated Lyme Carditis Leads to Death Read More »

Bannwarth Syndrome: Atypical Lyme Case With Weight Loss

Bannwarth Syndrome and Weight Loss: An Atypical Case of Neurologic Lyme Disease Bannwarth syndrome is a neurologic manifestation of Lyme disease most commonly described in Europe. However, cases are increasingly recognized in the United States. Physicians from the Mayo Clinic previously described several patients with neuroinvasive Lyme disease living in Minnesota and Wisconsin. In those

Bannwarth Syndrome: Atypical Lyme Case With Weight Loss Read More »

Lyme Disease Treatment Guidelines Strike Out

Lyme Disease Treatment Guidelines Strike Out: An Editorial There is growing evidence supporting the existence and severity of chronic manifestations of Lyme disease despite recent treatment guidelines for Lyme disease. Treatment guidelines influence how physicians diagnose and treat patients across the United States, and when they fail to reflect emerging clinical evidence, patients with persistent

Lyme Disease Treatment Guidelines Strike Out Read More »

189 Children Identified With Lyme Carditis in U.S. Study

Study Identifies 189 Children With Lyme Carditis Heart complications from Lyme disease extend far beyond classic heart block. A national study identified 189 children with Lyme carditis showing a broad spectrum of cardiac problems — from myocarditis to cardiac arrest — with median treatment costs exceeding $9,000 per child. By Dr. Daniel Cameron The Growing

189 Children Identified With Lyme Carditis in U.S. Study Read More »

Brain MRI in Lyme Disease: What Imaging May Reveal

Brain MRI in Lyme Disease: What Imaging May Reveal Brain imaging can help evaluate neurological symptoms in Lyme disease. However, MRI findings are often nonspecific, and a normal brain MRI does not rule out neurologic Lyme disease. By Dr. Daniel Cameron Brain MRI and Neurologic Lyme Disease Neurologic Lyme disease can affect the brain, spinal

Brain MRI in Lyme Disease: What Imaging May Reveal Read More »

C6 peptide test may indicate Borrelia miyamotoi infection

C6 peptide test may indicate Borrelia miyamotoi infection Koetsveld and colleagues examined C6 reactivity in sera from both mice infected with Borrelia miyamotoi and from 46 patients with PCR-confirmed Borrelia miyamotoi disease (BMD). Their findings suggest that the C6 peptide assay—commonly used in Lyme disease testing—may also serve as an indicator in a Borrelia miyamotoi

C6 peptide test may indicate Borrelia miyamotoi infection Read More »

Treatment of Lyme arthritis with disease-modifying antirheumatic drugs (DMARD)

Treatment of Lyme Arthritis: Are DMARDs Appropriate? The decision to use DMARD therapy in Lyme arthritis depends on whether persistent infection has been adequately treated or excluded. The treatment of Lyme arthritis with disease-modifying antirheumatic drugs (DMARDs) remains controversial. DMARDs are designed to slow inflammatory disease progression, but their role in Lyme arthritis depends on

Treatment of Lyme arthritis with disease-modifying antirheumatic drugs (DMARD) Read More »